3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Lymphoid
1
Conditions
Lymphoma, AIDS-Related
1
HIV Infections
1
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
Cyclophosphamide
12
Vincristine
10
Doxorubicin
10
Etoposide
8
Rituximab
6
Prednisone
6
Cytarabine
6
Dexamethasone
5
Bleomycin
5
Zidovudine
4
Methotrexate
4
Leucovorin
4
Filgrastim
4
Peripheral Blood Stem Cell Transplantation
3
sargramostim
2
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Vinblastine
2
Polymerase Chain Reaction
2
Melphalan
2
Dacarbazine
2
Carmustine
2
Antiretroviral Therapy, Highly Active
2
Allopurinol
2
prednylidene
1
pembrolizumab
1
liposomal doxorubicin
1
ibrutinib
1
efavirenz
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HIV Infections
×
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
×
Lymphoid
×
Clear all
NCT00799136
2013-09-12
CATCH
Ontario Clinical Oncology Group (OCOG)
Phase 2
Completed
6 enrolled